Stock Information

• Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
  Tue, May 5, 2026 5:16 PM
• Global Business Travel Group Posts Upbeat Q1 Results, Joins Cabaletta Bio, Aura Biosciences And Other Big Stocks Moving Higher On Monday
  Mon, May 4, 2026 9:54 AM
• Aura Biosciences announces pricing of $260 million public offering of common stock and pre-funded warrants
  Mon, May 4, 2026 9:17 AM
• Aura Biosciences Prices ~$260.3M Offering Of Common Shares, Pre-Funded Warrants
  Mon, May 4, 2026 9:09 AM
• Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
  Mon, May 4, 2026 8:02 AM
• Aura Plans Share Sale With Option for Additional Stock Purchase
  Mon, May 4, 2026 6:11 AM
• Aura Biosciences Names Natalie Holles as New CEO, Founder Elisabet de los Pinos, Ph.D. Steps Down, Nears Enrollment Completion for Late-Stage Cancer Trial
  Mon, May 4, 2026 6:09 AM
• Aura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
  Mon, May 4, 2026 6:03 AM
• Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion
  Mon, May 4, 2026 6:01 AM

Financial data not available